Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2

Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation

University of Colorado, Denver · NCT06141447

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
150
US sites recruiting
1
Study start
May 2, 2024
Record last updated
December 10, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.

Being studied: Oxytocin + normal saline; Normal saline

Conditions: Hemorrhage

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • clinic-based D\&E at 18 weeks gestational age and above
  • speaks English or Spanish

Exclusion Criteria

  • refuses IV
  • history of coagulopathy
  • anticoagulant use in the preceding five days
  • chorioamnionitis or sepsis
  • suspected placenta accreta spectrum
  • intrauterine fetal demise
  • multiple gestation
  • use of misoprostol for cervical preparation

Recruiting US locations

  • Comprehensive Women's Health Center

    Denver, CO 80230

    Site contact: Megan Masten, MD

Study contacts (from the official record)

  • Megan Masten, MD · 303-724-8576 · megan.masten@cuanschutz.edu
All healthy volunteers studies in Colorado →
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and… (NCT06141447) | Bored Studies